SREBF2 and Hypercholesterolemia: SREBF2 has also been shown to modulate cholesterol levels: the p.A595G polymorphism diminishes SREBF2 cleavage in vitro and is associated with higher cholesterol levels in patients with polygenic hypercholesterolemia [28].